Jubilant Pharmova Ltd.
BSE: 530019 | Sector: Health care |
NSE: JUBLPHARMA | ISIN Code: INE700A01033 |
BSE 09:34 | 30 Jan | 347.15 |
9.05 (2.68%) |
OPEN
332.05 |
HIGH
351.35 |
LOW
332.05 |
NSE 09:24 | 30 Jan | 344.30 |
6.65 (1.97%) |
OPEN
335.15 |
HIGH
344.35 |
LOW
335.15 |
OPEN | 332.05 |
PREVIOUS CLOSE | 338.10 |
VOLUME | 2141 |
52-Week high | 555.00 |
52-Week low | 305.20 |
P/E | 60.27 |
Mkt Cap.(Rs cr) | 5,530 |
Buy Price | 347.35 |
Buy Qty | 1.00 |
Sell Price | 347.95 |
Sell Qty | 5.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Jubilant Pharmova Ltd. (JUBLPHARMA) - Cash Flow
Figures in Rs crore | 2022 | 2021 | 2020 |
Opening Cash & Cash Equivalents | 40.33 | 35.64 | 18.70 |
Net Cash From Operating Activities | -3.55 | 608.38 | 316.76 |
Net Cash Used In/from Investing Activities | 93.10 | 177.96 | -197.71 |
Net Cash Used In/from Financing Activities | -107.37 | -781.65 | -41.05 |
Net (decrease)/increase In Cash and Cash Equivalents |
-17.82 | 4.69 | 78.00 |
Closing Cash & Cash Equivalents | 22.51 | 40.33 | 96.70 |
Quick Links for Jubilant Pharmova:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices